255 related articles for article (PubMed ID: 16102030)
1. Mechanisms of homocysteine-induced atherothrombosis.
Lentz SR
J Thromb Haemost; 2005 Aug; 3(8):1646-54. PubMed ID: 16102030
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of the atherogenic effects of elevated homocysteine in experimental models.
Wilson KM; Lentz SR
Semin Vasc Med; 2005 May; 5(2):163-71. PubMed ID: 16047268
[TBL] [Abstract][Full Text] [Related]
3. ADMA and hyperhomocysteinemia.
Dayal S; Lentz SR
Vasc Med; 2005 Jul; 10 Suppl 1():S27-33. PubMed ID: 16444866
[TBL] [Abstract][Full Text] [Related]
4. Role of redox reactions in the vascular phenotype of hyperhomocysteinemic animals.
Dayal S; Lentz SR
Antioxid Redox Signal; 2007 Nov; 9(11):1899-909. PubMed ID: 17822370
[TBL] [Abstract][Full Text] [Related]
5. [Hyperhomocysteinemia: an independent risk factor or a simple marker of vascular disease?. 1. Basic data].
Guilland JC; Favier A; Potier de Courcy G; Galan P; Hercberg S
Pathol Biol (Paris); 2003 Mar; 51(2):101-10. PubMed ID: 12801808
[TBL] [Abstract][Full Text] [Related]
6. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.
Stühlinger MC; Tsao PS; Her JH; Kimoto M; Balint RF; Cooke JP
Circulation; 2001 Nov; 104(21):2569-75. PubMed ID: 11714652
[TBL] [Abstract][Full Text] [Related]
7. Homocysteine-Induced Endothelial Dysfunction.
Lai WK; Kan MY
Ann Nutr Metab; 2015; 67(1):1-12. PubMed ID: 26201664
[TBL] [Abstract][Full Text] [Related]
8. Protective vascular and cardiac effects of inducible nitric oxide synthase in mice with hyperhomocysteinemia.
Dayal S; Blokhin IO; Erger RA; Jensen M; Arning E; Stevens JW; Bottiglieri T; Faraci FM; Lentz SR
PLoS One; 2014; 9(9):e107734. PubMed ID: 25226386
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of increased vascular oxidant stress in hyperhomocys-teinemia and its impact on endothelial function.
Weiss N
Curr Drug Metab; 2005 Feb; 6(1):27-36. PubMed ID: 15720205
[TBL] [Abstract][Full Text] [Related]
10. Murine models of hyperhomocysteinemia and their vascular phenotypes.
Dayal S; Lentz SR
Arterioscler Thromb Vasc Biol; 2008 Sep; 28(9):1596-605. PubMed ID: 18556571
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
Dayal S; Rodionov RN; Arning E; Bottiglieri T; Kimoto M; Murry DJ; Cooke JP; Faraci FM; Lentz SR
Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H816-25. PubMed ID: 18567702
[TBL] [Abstract][Full Text] [Related]
12. Endothelial dysfunction and atherothrombosis in mild hyperhomocysteinemia.
Weiss N; Keller C; Hoffmann U; Loscalzo J
Vasc Med; 2002 Aug; 7(3):227-39. PubMed ID: 12553746
[TBL] [Abstract][Full Text] [Related]
13. Influence of hyperhomocysteinemia on the cellular redox state--impact on homocysteine-induced endothelial dysfunction.
Weiss N; Heydrick SJ; Postea O; Keller C; Keaney JF; Loscalzo J
Clin Chem Lab Med; 2003 Nov; 41(11):1455-61. PubMed ID: 14656025
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in patients with peripheral arterial disease and chronic hyperhomocysteinemia: potential role of ADMA.
Sydow K; Hornig B; Arakawa N; Bode-Böger SM; Tsikas D; Münzel T; Böger RH
Vasc Med; 2004 May; 9(2):93-101. PubMed ID: 15521698
[TBL] [Abstract][Full Text] [Related]
15. Role of hyperhomocysteinemia in endothelial dysfunction and atherothrombotic disease.
Austin RC; Lentz SR; Werstuck GH
Cell Death Differ; 2004 Jul; 11 Suppl 1():S56-64. PubMed ID: 15243582
[TBL] [Abstract][Full Text] [Related]
16. Plasma asymmetric and symmetric dimethylarginine in a rat model of endothelial dysfunction induced by acute hyperhomocysteinemia.
Magné J; Huneau JF; Borderie D; Mathé V; Bos C; Mariotti F
Amino Acids; 2015 Sep; 47(9):1975-82. PubMed ID: 25792109
[TBL] [Abstract][Full Text] [Related]
17. Folic acid reduces adhesion molecules VCAM-1 expession in aortic of rats with hyperhomocysteinemia.
Li M; Chen J; Li YS; Feng YB; Gu X; Shi CZ
Int J Cardiol; 2006 Jan; 106(2):285-8. PubMed ID: 16183151
[TBL] [Abstract][Full Text] [Related]
18. Homocysteine and glutathione peroxidase-1.
Lubos E; Loscalzo J; Handy DE
Antioxid Redox Signal; 2007 Nov; 9(11):1923-40. PubMed ID: 17822368
[TBL] [Abstract][Full Text] [Related]
19. Interactions of homocysteine, nitric oxide, folate and radicals in the progressively damaged endothelium.
Stanger O; Weger M
Clin Chem Lab Med; 2003 Nov; 41(11):1444-54. PubMed ID: 14656024
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia, endothelial dysfunction, and cardiovascular risk: the potential role of ADMA.
Lentz SR; Rodionov RN; Dayal S
Atheroscler Suppl; 2003 Dec; 4(4):61-5. PubMed ID: 14664904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
